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Background: The nucleosome remodeling and histone deacetylase complex (Mi2/NRD/NuRD/NURD) has a broad
role in regulation of transcription, DNA repair and cell cycle. Previous studies have revealed a specific interaction
between NURD and histone H3N-terminal tail in vitro that is not observed for another HDAC1/2-containing
complex, Sin3A. However, the subunit(s) responsible for specific binding of H3 by NURD has not been defined.
Results: In this study, we show among several class I HDAC-containing corepressor complexes only NURD exhibits
a substantial H3 tail-binding activity in vitro. We present the evidence that the MTA family proteins within the
NURD complex interact directly with H3 tail. Extensive in vitro binding assays mapped the H3 tail-binding domain
to the C-terminal region of MTA1 and MTA2. Significantly, although the MTA1 and MTA2 mutant proteins with
deletion of the C-terminal H3 tail binding domain were assembled into the endogenous NURD complex when
expressed in mammalian cells, the resulting NURD complexes were deficient in binding H3 tail in vitro, indicating
that the MTA family proteins are required for the observed specific binding of H3 tail peptide by NURD in vitro.
However, chromatin fractionation experiments show that the NURD complexes with impaired MTA1/2-H3 tail
binding activity remained to be associated with chromatin in cells.
Conclusions: Together our study reveals a novel histone H3-binding activity for the MTA family proteins and
provides evidence that the MTA family proteins mediate the in vitro specific binding of H3 tail peptide by NURD
complex. However, multiple mechanisms are likely to contribute to the chromatin association of NURD complex in
cells. Our finding also raises the possibility that the MTA family proteins may exert their diverse biological functions
at least in part through their direct interaction with H3 tail.
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Histone lysine acetylation plays a central role in the epi-
genetic regulation of gene expression [1-3]. The levels of
histone acetylation in eukaryotic cells are governed by
the opposing activities of histone acetyltransferases
(HATs) and histone deacetylases (HDACs) [3]. The
mammalian genome encodes a significant number of
HDACs, among them are the abundantly and ubiqui-
tously expressed class I HDACs that include HDAC1,
HDAC2 and HDAC3 [3]. The class I HDACs are mainly
found in stable multi-subunit complexes with co-* Correspondence: jmweng@bio.ecnu.edu.cn
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reproduction in any medium, provided the orrepressor proteins like Sin3A [4,5], CoREST [6,7],
CHD3/CHD4(Mi2-α/β) [8,9] and NCoR/SMRT [10,11].
The NURD complexes, also widely known as Mi-2/
NRD/NuRD complexes [8,9,12,13], have been independ-
ently purified from various sources. Although the NURD
complexes purified by different laboratories vary slightly
in compositions, it is generally agreed that the NURD
complex contains either CHD3 (also known as Mi2-α)
or CHD4 (also known as Mi2-β), HDAC1 and HDAC2,
RbAp46 (also known as Rbbp7) and RbAp48 (also
known as Rbbp4), MTA1/2/3, MBD3, and p66α and
p66β subunits [14]. The presence of CHD3 or CHD4
subunit renders the NURD complex the unique ATP-
dependent chromatin remodeling activity that is coupled
with HDAC activity [8,9,12,13]. Of note, the MTA family
proteins MTA1 (metastasis-associated gene 1), MTA2
and MTA3 form exclusive NURD complex. The NURD. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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shown to have important and broad roles in transcrip-
tion, DNA repair, cell cycle and genome stability [15,16].
In principle, various HDAC complexes can play a role
in histone deacetylation either through a recruitment
mechanism via interaction with sequence-specific tran-
scription factors or chromatin associated proteins and/
or direct interaction with chromatin [17,18]. In this re-
gard, previous studies demonstrated that the NURD, but
not the similar Sin3A complex that share with NURD
the core HDAC1/2 and RbAp46/48 subcomplex, inter-
acts with the histone H3N-terminal tail in vitro [19,20].
In fact, the NURD complex appeared to be the major
H3 tail peptide-proteins in the HeLa nuclear extracts.
Furthermore, the NURD-H3 interaction is diminished
when H3K4 site is methylated [19,20]. While this out-
standing interaction with H3 tail implies a critical role of
NURD complex in control of histone acetylation, sur-
prisingly it is not yet clear what protein subunit(s) within
the NURD complex is responsible for this specific inter-
action with H3 tail. As the core HDAC1/2 and RbAp46/
48 subcomplex is common between Sin3A and NURD,
efforts have been focused on the proteins unique to the
NURD complex including CHD3/4 and p66α and p66β
subunits. The CHD3 and CHD4 are attractive candidates
since both proteins contain two PHD domains [21].
PHD domains from various proteins have emerged as
methylated and unmodified histone binding modules
[22]. Musselman et al. reported the interaction of the
second PHD domain in CHD4 with H3 tail peptide and
more recently the bivalent recognition of two H3 tails in
a nucleosome by CHD4 tandem PHD domains [23,24].
However, it is unclear if CHD4 and/or CHD3 are re-
sponsible for the observed H3-binding activity of the
NURD complex. Another study reported the interaction
of p66α and p66β subunits with histones [25]. However,
the p66α and p66β subunits were found to interact with
not only H3 but also H2A, H2B and H4, a result incon-
sistent with the observed specific interaction of NURD
with H3 but not other histone N-terminal tails [19,20].
Thus, exactly how the NURD complex recognizes specif-
ically H3 tail remains to be determined.
In this study, we have investigated the H3 tail binding
specificity of individual subunits of NURD complex and
present the evidence that the MTA family proteins are
novel histone H3 binding proteins. MTA1, the founding
member of the MTA family proteins that include MTA1,
MTA2 and MTA3, was initially identified as a metastasis-
associated tumor gene [26,27]. Previous studies indicated
that the MTA proteins form exclusive alternative NURD
complexes and have broad function in transcriptional
regulation [28,29]. Furthermore, previous study indicated
that the MTA1 can also form a core complex contai-
ning other subunits of NURD complex except CHD3or CHD4 [30]. We mapped the H3 binding activity to
the C-terminus of MTA1 and MTA2. We present the evi-
dence that the MTA family proteins within the NURD
complex interact directly with H3 tail and this interaction
most likely accounts for the observed specific binding of
H3 tail peptide by NURD in vitro. However, chromatin
fractionation experiments show that the NURD com-
plexes with impaired MTA1/2-H3 tail binding activity
remained to be associated with chromatin in cells. Our
study provides new insight for binding of chromatin by
NURD and uncovers a novel histone-binding activity for
MTA family proteins.
Results
Unique and robust binding of H3 tail peptide by NURD
but not other class I HDAC complexes
To identify proteins that potentially read the unmodified
histone H3N-terminal tail, we synthesized a H3 1–21 aa
peptide with a C-terminal biotin moiety. This peptide was
first immobilized onto the streptavidin agarose beads and
then incubated with proteins in HeLa nuclear extracts.
After extensive washes, the proteins that bound to the
beads were boiled in SDS-loading buffer, resolved with a
4-20% SDS-PAGE gel and visualized by coomassie blue
staining (Figure 1A). The resulting H3 peptide-binding
protein bands were excised, digested with trypsin in-gel,
and subjected to protein identification by mass spectrom-
etry. As shown in Figure 1A, all the major protein bands
were identified as components of the mammalian NURD
complex [8,9,12,13], including the CHD3/4, MTA1/2/3,
p66α/β, HDAC1/2, RbAp46/48 and MDB3. In fact, the
protein band pattern in Figure 1A is essentially identical
to the NURD protein complex extensively purified by
conventional and immunoaffinity chromatography as re-
ported previously [8,9]. This result is in well agreement
with previous studies [19,20], and clearly demonstrated
that the NURD complex is the major and abundant his-
tone H3N-terminal tail-binding proteins at least in the
HeLa nuclear extracts.
In addition to the NURD complexes, HeLa nuclear
extracts contain also abundantly the HDAC1/2-contain-
ing Sin3A and CoREST complexes. However, in our
mass spectrometry analysis we did not identify any pro-
teins that are unique to Sin3A, a result consistent with
previous studies [19,20]. Furthermore, we also failed to
identify unique components of the CoREST complexes,
indicating both Sin3A and CoREST corepressor com-
plexes did not bind the H3 peptide under our experi-
mental conditions. To test this further, we carried out
pulldown assays with biotinylated H2A, H2B, H3 and
H4N-terminal peptides and HeLa nuclear extracts, and
the resulting binding proteins were analyzed by western
blot using antibody against Sin3A and CoREST. Consist-


















































































Figure 1 Unique binding of H3 tail peptide by NURD but not other class I HDAC complexes. A. Coomassie blue staining revealed the H3
tail peptide-binding proteins isolated from HeLa nuclear extracts. The identities of the protein bands were determined by mass spectrometry. ‘-‘,
the beads only control. B. Among several class I HDAC complexes only NURD exhibited a substantial H3 tail-binding activity in vitro. The HeLa
nuclear extracts were incubated with various immobilized histone tails in vitro and the binding of various class I HDAC complexes was examined
by western blot analysis using antibodies against complex-specific subunits. Sin3A, the unique subunit of the Sin3A/HDAC1/2 complex; CoREST,
the unique subunit of CoREST complex; MTA1/2, the unique subunits of NURD; NCoR, the unique subunit of NCoR/SMRT/HDAC3 complex. C. The
binding specificity of NURD complexes toward histone H3 tail peptides. The HeLa nuclear extracts were incubated with the immobilized histone
tail peptides as indicated and the binding of NURD complexes was examined by subsequent western blot analysis using antibodies against
CHD3, CHD4, MTA1 and HDAC1. PHF8 served as a positive control for H3K4me2/3-binding proteins.
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detected the significant enrichment of MTA1 and MTA2
in the H3 but not other histone peptides-bound frac-
tions. As expected, western blot analysis also detected
the enrichment of RbAp48 by H3 but not other peptides.
However, Sin3A and CoREST were detected only in the
input but not in the H3 bound fraction (Figure 1B).
Similarly, we found that the NCoR/SMRT corepressor
complexes, which contain HDAC3 but not HDAC1/2,
were present in the input but not in the bound fraction.
Together these data extend previous observation [19,20]
to that the NURD but not other class I HDAC com-
plexes exhibits a unique and robust H3 tail-binding
activity.
Previous studies indicated that H3K4 methylation sub-
stantially inhibited the H3-binding activity of NURD
[19,20]. We confirmed that H3K4 mono-, di-and tri-
methylation all inhibited the binding of NURD to H3
peptide (Figure 1C). As a control, PHF8 was found to
bind preferentially the K4me3 peptide (Figure 1C)[31,32]. Interestingly, we observed that while K9me1 and
K9me2 did not obviously affect the binding of NURD,
K9me3 appeared to inhibit the binding.
Within the NURD complexes the MTA proteins directly
bind H3 tail peptide
To identify the protein(s) within the NURD complexes
that directly binds the H3 tail peptide, we first expressed
and labeled each individual NURD subunit with 35S-me-
thionine by in vitro coupled transcription and translation
reactions. These proteins were then tested for binding of
H3 and H3K4me3, H3K9me3 and acetylated H3 pep-
tides by in vitro pulldown assay. Interestingly, we found
that all subunits except MBD3 were able to bind the H3
peptide (Figure 2A). However, the binding of HDAC1 and
p66α appeared to be non-specific, as both proteins were
retained by the control beads and their binding was not
affected by H3K4me3. Although RbAp48 exhibited a
unique H3-binding specificity that is diminished with
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Figure 2 The MTA family subunits bind directly the H3 tail peptide. A. the H3 tail peptide-binding specificity of individual subunits of NURD
complex. Each subunit of NURD complex was synthesized and 35S-met labeled via in vitro coupled transcription and translation. The proteins
were then subjected to in vitro pulldown with immobilized H3 tail peptides as indicated. The binding was visualized by autoradiography. Note
that the MTA1 family proteins, CHD3 and RbAp48 bound H3 tail in a H3K4me3-sensitive manner, whereas p66/68 and HDAC1 were not. B. UV-
induced cross-linking demonstrated a direct association of MTA family proteins with H3 tail peptide. The H3(Bpa) peptide contained at K9
position a Bpa moiety that mediated a UV-induced cross-linking with associated protein(s) in close proximity. Note that once cross-linked to the
H3(Bpa) peptide, the associated protein(s) became resistant to wash with 0.2% SDS buffer.
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present in the Sin3A complex that does not to bind H3
peptide (Also see Figure 3). Together these results point to
CHD3 and MTA family proteins as potential candidates
responsible for binding of H3 by NURD.
To test further if CHD3/4 and/or MTA family proteins
mediate the binding of H3 by NURD, we resorted to a
widely used benzoylphenylalanine(BPa)-based, photo-
induced cross-linking technique [33,34]. BPa can form co-
valent bonds with proteins in a close proximity (3 Å
radius) when irradiated by UV light at 360 nm. A H3 pep-
tide with K9 replaced by a Bpa residue was synthesized.
We chose to have the bulky cross-linking residue Bpa at
K9 position because K9 is not the key residue for binding
of NURD, but likely lies at the edge of the H3 sequence
required for binding of NURD. In agreement with this
idea, the H3Bpa peptide was able to bind NURD as theregular H3 peptide (Figure 2B, compare lanes 8–10 with
lanes 2–4). In the absence of UV treatment, we observed
that the binding of NURD to both H3 and H3Bpa peptides
could be stripped from the H3 peptide by washing buffer
containing 0.2% SDS (Figure 2B, compare lane 5 with
lanes 2–4 and compare lane 11 with lanes 8–10). Import-
antly, we found that after UV treatment the binding of
MTA1/2 to H3Bpa peptide but not the H3 peptide be-
came resistant to 0.2% SDS washing (Figure 2B, compare
lanes 12 and 13 with lane 11). In contrast, under the same
condition the binding of CHD3 and CHD4 to the H3Bpa
peptide was sensitive to 0.2% SDS washing. Similarly, the
binding of HDAC1 and HDAC2, detected as a doublet in
Western blot, to H3Bpa peptide was also sensitive to 0.2%
SDS washing even after UV irradiation. We took this re-
sult to conclude that within the NURD complex MTA1/2
but not CHD3/4 were associated directly with the H3Bpa
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upon UV treatment. To test if MTA3 also binds directly
to H3 peptide, we carried out the same experiment with
the whole cell extracts derived from Flag-MTA3 expres-
sing HeLa cells. We observed a UV-treatment dependent,
0.2% SDS resistant association of Flag-MTA3 with the
H3Bpa but not the control H3 peptide (Figure 2B). To-
gether these data provide the first evidence that the MTA
family proteins directly associate with H3 peptide and thus
mediate the binding of H3 tail by NURD.
The H3 binding activity is localized to the C-terminal
regions of MTA proteins
To determine the region of MTA1 responsible for binding
of H3 peptide, we constructed a series of MTA1 deletion
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Figure 3 The H3BD of MTA1 and MTA2 mediates the in vitro binding
but not MTA1(454–715) was incorporated into the core HDAC1/2 and RbA
regions were expressed in 293T cells and assayed for association with othe
terminal but not the C-terminal region of MTA1 associated with HDAC1/2
MTA1. Input, 10%. B. The MTA1 C-terminal region but not the N-terminal re
complex bound the H3 tail peptide in in vitro pulldown assay. The sample
was detected for Flag-MTA1(1–460), whereas Flag-MTA1(454–715) bound t
terminal region of MTA1 binds H3 tail peptide independent of HDAC1/2 an
MTA1(454–715) were purified as illustrated in the top panel and then subje
Mammalian expressed MTA2(1–434) but not MTA2(427–668) was incorpora
terminal regions were expressed in 293T cells and assayed for association w
the N-terminal but not the C-terminal region of MTA2 associated with HDA
terminal region that was incorporated into the endogenous NURD comple
D were subjected to in vitro pulldown assay. Input, 10%.labeled proteins by in vitro coupled transcription and trans-
lation and tested for binding to H3 tails by in vitro peptide
pulldown assay. Despite the presence of SANT domain that
has been implicated in binding of histones [35], we were
surprised to see that all the N-terminal MTA1 constructs
failed to bind H3 peptide (Figure 3A). Furthermore, the
N-terminal regions including the BAH, Elm2, SANT and
ZnF domains were not required for binding, as the mu-
tants with the N-terminal deletions up to aa454 (construct
454–715) maintained the robust H3 binding activity. How-
ever, further deletion up to aa544 substantially reduced the
H3 binding activity, indicating the region between aa454-
544 is required for efficient binding of H3 peptide. As the
aa454-544 and aa454-630 mutants displayed substantially
reduced H3 binding activity, a broad region within the
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p46/48 containing complex. The MTA1 and its N- and C-terminal
r subunits of NURD complex by IP-western analysis. Note that the N-
and RbAp48 and that no association with CHD4 was detected for
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he H3 tail peptide as efficient as Flag-MTA1. Input, 10%. C. The C-
d RbAp48. The 293T-expressed, Flag-tagged MTA1, MTA1(1–460) and
cted to in vitro pulldown assay for binding of H3 tail peptide. D.
ted into the endogenous NURD complex. The MTA2 and its N- and C-
ith other subunits of NURD complex by IP-western analysis. Note that
C1/2 and CHD4. Input, 10%. E. The C-terminal region but not the N-
x bound the H3 tail peptide in in vitro pulldown assay. The samples in
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Figure 4 The H3 -binding domain (H3BD) resides within the C-terminal regions of MTA proteins. A. The binding of various MTA1 deletion
mutants to H3 tail peptide in vitro. The left panel illustrates the primary structures of MTA1 and various mutants. Also indicated are four structural
motifs in the N-terminal regions of MTA proteins, namely BAH, ELM2, SANT and ZnF and the C-terminal H3BD determined here. The proteins
were synthesized and 35S-met labeled and subjected to in vitro pulldown assay with and without the immobilized H3 peptide. B. The C-terminal
region of MTA1 exhibits the same H3 peptide-binding specificity as the full-length MTA1. The experiment was performed as in B except
additional immobilized H3 peptides were included. C. The recombinant MTA1 and MTA2 C-terminal regions are sufficient for binding H3 tail
peptide. The 6xHis-tagged MTA1(454–715) and 6xHis-MTA2(427–668) were expressed and purified from E.coli and subjected to in vitro pulldown
assay with immobilized H3 tail peptide. D. The H3-binding activity is also mapped to the C-terminal region of MTA2. The MTA2 and its N- and
C- terminal regions were expressed as 35S-Met labeled proteins and subjected to in vitro pulldown assay with immobilized H3 tail peptide.
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module within the C-terminal region, as internal deletion
of either aa454–508 or aa507-657 in the full-length MTA1
all reduced but did not abolished the H3 binding activity
(Figure 4A).
To test further if the C-terminal region is responsible for
binding of H3 peptide by MTA1, we also examined if the
binding of MTA1(454–715) to H3 peptides was affected
by H3 posttranslational modifications as the full-length
MTA1. The results in Figure 3B showed that MTA1(454–
715) exhibited the same binding specificity as the full
length MTA1, ranging from slightly reduced binding to
both acetylated and H3K9 methylated H3 peptides and
substantially reduced binding to the H3K4me3 peptide.
To test if MTA1 binds directly the H3 tail peptide, we
expressed and purified recombinant 6xHis-MTA1(454–
715) from E.coli. Although this protein was not well
expressed in E.coli, we were able to prepare enough for
in vitro pulldown assay using immobilized H3 peptide.
Coomassie blue staining revealed the specific binding of
this recombinant protein to the immobilized H3 but not
control beads (Figure 3C, upper panel). Taking together,
these data allowed us to assign the H3 binding activity
to the MTA1 C-terminal region that is not known for
any recognizable structural and functional domain. We
designated this newly identified H3-binding domain as
H3BD, although the precise region of H3BD remained
to be further defined.
The MTA2 also has a C-terminal H3BD
Among the MTA family proteins, the C-terminal
regions are in fact less conserved in sequences in com-
parison to the N-terminal regions. We next wished to
determine if the the H3 binding activity of MTA2 also
resides in its C-terminal domain. We tested this first
by comparing the binding of in vitro translated MTA2
N-terminal fragment (1–434) and C-terminal fragment
(427–668) to the H3 tail peptide in pullodwn assay. As
shown in Figure 3D, the H3 binding activity was observed
for the C-terminal region of MTA2 but not the N-
terminal region. Furthermore, we expressed and purified
the recombinant 6×His-MTA2(427–668) from E.coli. This
recombinant protein was capable of binding H3 peptide
as efficient as the recombinant MTA1 C-terminal domain
(Figure 4C). Thus, like MTA1, the H3 binding activity of
MTA2 also resides in its C-terminal domain.
The C-terminal H3BD of MTA1 mediates the binding of
H3 peptide by the core MTA1-HDAC1/2-RbAp46/48
complex
Having established that the MTA1 binds H3 tail peptide
in vitro through its C-terminal H3BD, we next investi-
gated if the H3BD of MTA1 mediates the binding of H3
peptide by NURD. For this purpose, we first expressedFlag-tagged MTA1, MTA1(1–460) and MTA1(454–715)
in 293T cells and analyzed if they interacted with the en-
dogenous HDAC1/2 and thus were incorporated into
endogenous NURD complex. As shown in Figure 4A, all
three proteins were expressed and could be efficiently
immunoprecipitated using anti-Flag M2 beads. As
expected, both HDAC1/2 and RbAp48 were efficiently
co-immunoprecipitated with the full-length Flag-MTA1
(Figure 3A), indicating that the ectopically expressed
Flag-MTA1 interacted with endogenous HDAC1/2 and
RbAp46/48. Consistent with a previous study [28], we
found CHD4 was poorly co-immunoprecipitated with
the Flag-MTA1, indicating that ectopically expressed
Flag-MTA1 was assembled into a core complex with
HDAC1/2 and RbAp46/48 but without CHD3/4. Under
the same experimental conditions, we found that MTA1
N-terminal region (F-1-460) was associated with
HDAC1/2 and RbAp48, whereas the C-terminal frag-
ment (F-454-715) was not (Figure 4A). Together these
results indicate that the N-terminal 1–460 of MTA1 is
sufficient for interaction and incorporation into the
HDAC1/2 and RbAp46/48 core complex, whereas the
C-terminal 454–715 is not incorporated into the
complex.
We next analyzed the H3 tail binding property for the
MTA1 proteins expressed in 293T cells. Significantly,
in vitro peptide pulldown assay in Figure 4B showed that
the Flag-MTA1(454–715) bound the H3 tail peptide as
efficiently as full-length Flag-MTA1, whereas no binding
was detected for Flag-MTA1(1–460).
To substantiate the above results further, we isolated
Flag-tagged MTA1, MTA1(1–460) and MTA1(454–715)
via anti-Flag immune-affinity purification as illustrated in
the top panel of Figure 4C. The eluted proteins were then
subjected to in vitro binding of H3 tail peptide by pull-
down assay. The representative results in Figure 4C
showed that the immune-affinity-purified Flag-MTA1 and
its associated HDAC1/2 and RbAp48 were retained by
immobilized H3 tail peptides. However, while the purified
Flag-MTA1(454–715) that contained no HDAC1/2 and
RbAp48 was retained by the immobilized H3 peptides,
Flag-MTA1(1–460) and its associated HDAC1/2 and
RbAp48 were retained poorly, if any. Taken together, these
data showed that 293T-expressed Flag-MTA1(1–460)
formed complex with endogenous HDAC1/2 and
RbAp46/48 but exhibited a poor H3 tail-binding activity,
whereas the C-terminal H3BD of MTA1 bound H3 pep-
tide in the absence of HDAC1/2 and RbAp46/48 as effi-
ciently as the full-length MTA1.
Unlike MTA1, ectopically expressed MTA2 is known to
be assembled into the NURD complex containing
HDAC1/2, RbAp46/48 and CHD3/4 -[28]. This provides
us an opportunity to test the role of MTA2 C-terminal
H3BD in the context of full NURD complex. We next
Wu et al. Cell & Bioscience 2013, 3:1 Page 8 of 14
http://www.cellandbioscience.com/content/3/1/1expressed Flag-tagged full-length MTA2, the MTA2
N-terminal region 1–434 and C-terminal region 427–668
in 293T cells and analyzed their association with endogen-
ous HDAC1/2, and CHD4 by IP-WB analysis. As shown in
Figure 4D, immunoprecipitation of the full-length MTA2
and the N-terminal fragment MTA2 1–434 using anti-Flag
M2 beads brought down HDAC1 as well as CHD4. How-
ever, the co-immunoprecipitation with HDAC1 and CHD4
was not observed for the Flag-tagged MTA2 C-terminal
427–668 fragment. Given that the MTA proteins are
known to form exclusive NURD complexes (MTA1 or
MTA2 or MTA3 does not co-exist in the same NURD
complex), the co-immunoprecipitation of MTA2 1–434
fragment with CHD4 and HADC1/2 implied the incorp-
oration of MTA2 1–434 fragment into the NURD com-
plex by replacement of endogenous MTA proteins. When
the above three 293T-expressed MTA2 proteins were sub-
jected to in vitro peptide pulldown assay, we found that
the C-terminal region free of other subunits of NURD
complex was able to bind H3 tail peptide as efficient as
the full-length MTA2, whereas no significant binding was
observed for the N-terminal fragment that was incorpo-
rated into the endogenous NURD complex (Figure 4E).
As the MTA2 1–434 fragment was incorporated into the
NURD complex containing CHD3/4 presumably by re-
placing endogenous MTA proteins, yet no significant
binding of H3 tail peptide was observed for the NURD
complex containing the MTA2 1–434 fragment, this result
provides a strong evidence that the MTA proteins are
required for binding of H3 tail-peptide by NURD in vitro.
Together these results provide compelling evidence that
the MTA1 and MTA2 mediate the observed H3 tail pep-
tide binding by NURD complex in vitro and this binding
requires their C-terminal H3BD.
The existence of H3-MTA interaction independent
mechanism for NURD chromatin association
This far we have provided multiple lines of evidences that
the in vitro specific binding of H3 tail peptide by NURD
is likely mediated through the C-terminal H3BD of
MTA family proteins. Next we wished to determine if the
H3-MTA interaction is required for chromatin association
of NURD complex in cells. For this purpose, we used a set
of GFP-tagged MTA1 proteins that exhibited a high level
of expression than the corresponding Flag-MTA1 proteins
(data not shown). We first verified that like Flag-MTA1
(1–460), the GFP-MTA1(1–460) expressed in 293T cells
also bound poorly to the H3 tail peptide, whereas a robust
binding was observed for GFP-MTA1(454–715) in a typical
in vitro pulldown assay (Figure 5A). We then expressed
GFP-MTA1, GFP-MTA1(1–460) and GFP-MTA1(454–
715) in 293T cells by transient transfection and analyzed
their chromatin association by cellular fractionation (see
Materials and Methods). A representative result inFigure 5B shows that all three proteins were mainly
detected in the chromatin fraction and the chromatin asso-
ciation was resistant to the salt extraction upon to 350 mM
NaCl. Under the same experimental conditions, we found
that the control GFP was dominantly presented in the cyto-
plasmic. Similarly, the endogenous HSP90 proteins were
detected primarily in the cytoplasmic. As an internal con-
trol for chromatin fractionation, the endogenous DNMT1
was shown to be mainly chromatin associated and could be
efficiently extracted from the chromatin by the buffer with
250 mM NaCl, a result consistent with a previous study
[36]. These results indicate that although the MTA(1–460)
fragment does not bind H3 tail peptide in vitro, it is never-
theless associated with chromatin in cells.
To further substantiate the above observation and to
compare the chromatin association of MTA1(1–460) and
MTA1(454–715) directly, we co-transfected both GFP-
tagged MTA1 proteins into 293T cells. The cells were trea-
ted with 1% formaldehyde for 10 min to preserve the inter-
action of chromatin associated proteins with chromatin.
We then prepared 293T cell nuclei and digested the nuclei
with MNase to release chromatin into soluble fraction. The
sucrose gradient (5–30%) centrifugation was then employed
to separate chromatin into mononucleosomes and oligonu-
cleosomes as judged on the basis of the sizes of DNA frag-
ments (Figure 5C). The same fractions were then subjected
to WB analysis for GFP-MTA proteins and H2B for detec-
tion of chromatin (Figure 5D). A comparison of results in
Figure 5C and Figure 5D shows a nice correlation between
the fractions containing nucleosomal DNA and fractions
containing H2B, allowing us to identify the chromatin-
containing fractions. The WB analyses using anti-GFP anti-
body revealed the enrichment of both GFP-MTA1(1–460)
and GFP-MTA1(454–715) in the chromatin-containing
fractions. No co-immunoprecipitation was observed be-
tween GFP-MTA1(1–460) and GFP-MTA1(454–715) (data
not shown), thus excluding the possibility for the two
MTA1 fragments to form a functional complex through
complementation. Together with the salt extraction experi-
ment, these results indicate that despite of its lack of H3
binding activity, the MTA1(1–460) fragment is associated
with chromatin in cells. As the MTA1(1–460) fragment is
incorporated into the HDAC1/2 and RbAp48-containing
NURD complex(es), our results indicate the existence of
MTA1-H3 interaction independent mechanism for associ-
ation of NURD complex with chromatin.
Discussion
NURD is the only class I HDAC complex that binds the H3
tail with a high affinity in vitro
Accumulating evidence has demonstrated diverse roles of
histone modifications in transcription and other DNA-
based biological processes. In principle histone modification
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Figure 5 The H3-MTA interaction independent mechanism exists for NURD chromatin association. A. Pulldown assay using GFP-tagged
MTA1 proteins confirmed the MTA1 C-terminal H3 binding activity. Note that a very weak H3 binding activity was detected for N-terminal MTA1
with intensive exposure. B. Both the N-terminal and C-terminal GFP-MTA1 were chromatin associated in 293T cells. The 293T cells were
transfected with GFP-MTA1, GFP-MTA1(1–460) and GFP-MTA1(454–715) and the resulting cells were subjected to cellular fractionation of soluble
cellular fraction and insoluble chromatin fraction as described in Materials and Methods. The fractions were further extracted with buffer
containing different concentration of NaCl as indicated to generate different fractions. Note that while DNMT1 was gradually stripped from
chromatin by an increasing salt concentration, all three MTA1 proteins essentially remained to be associated with chromatin. C. Fractionation of
soluble chromatin fragments derived from MNase digestion by a 5–30% sucrose gradient centrifugation. The soluble chromatin was prepared
from the 293T cells expressing both GFP-MTA1(1–460) and GFP-MTA1(454–715). After sucrose gradient centrifugation, consecutive fractions
(300 μl each) were collected from top. Half of the samples were used for preparation of DNA and analyzed by agarose gel electrophoresis. D. The
remaining half of the sucrose gradient fractionation samples was subjected to protein precipitation by TCA and resolved by SDS-PAGE. After
transfer to nitrocellulose membrane, the proteins were revealed by Ponceau S staining (top panel) and then analyzed by western blot. Note that
the majority of GFP-MTA1(1–460) and GFP-MTA1(454–715) were present in the chromatin fractions.
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indirectly through interaction with transcription factors or
secondary regulatory proteins. Among numerous histone
modification enzymes studied a recurrent theme is that the
enzymes or their associated protein complexes are capable
of interacting with histones [37,38]. For example, CBP and
p300, two well characterized histone acetyltransferases,
contain a bromodomain that recognizes acetylated lysine.
The HDAC1/2-containing Sin3A corepressor complex hasbeen shown to interact with chromatin through its asso-
ciated RbAp46/48 subunits [39], whereas the NCoR/SMRT
corepressor complex may interact with chromatin through
the TBL1/TBLR1 subunits [40] and NCoR/SMRT [41].
However, as reported previously and confirmed in this
study [19,20], the NURD complex represents the major H3
tail-binding proteins in HeLa nuclear extracts. Despite the
reported RdAp46/48-histone interaction, the mSin3A com-
plex was not observed to bind the H3 tail peptide under
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NCoR/SMRT complexes were not observed to bind H3
tails under the same condition (Figure 1C). Thus, the
NURD complex is unique among all class I HDAC core-
pressor complexes tested for its specific interaction with
histone H3 tail in vitro. As NURD is highly conserved in
evolution and ubiquitously and abundantly expressed in
cells, the specific interaction with histone H3 tail is likely to
render NURD a unique role in global deacetylation of chro-
matin, in addition to specific targeting by various transcrip-
tion factors including ikaros [42]. This idea is consistent
with the widespread roles of NURD in transcription repres-
sion, DNA damage repair, cell cycle progression and gen-
ome stability [14,43-45].
MTA family proteins as novel H3 binding proteins
A surprising finding in our study is that the MTA family
proteins in the NURD complex are novel H3 binding pro-
teins that are likely to account for specific binding of H3
tail peptide in vitro by NURD. The MTA family proteins,
especially MTA1, have been shown to play important roles
in diverse processes including transcriptional regulation,
DNA damage repair and cancer [27,29,46-48]. Interest-
ingly, MTA1 seemed to differ from MTA2 in association
with CHD3/CHD4 as reported in a previous study [28].
The ectopically expressed MTA2 was shown to assemble
into the CHD3/4-containig NURD complex, whereas
ectopically expressed MTA1 was shown to form the pro-
tein complexes containing HDAC1/2 and RbAp46/48 but
lacking CHD3/CHD4. In our effort to determining the
protein subunit(s) responsible for H3 tail binding activity,
we observed that the CHD3, MTA family proteins and
RbAp48 all exhibited a H3 tail peptide binding specificity
resembling to that of NURD (Figure 2A). However, our
photo-induced cross-linking experiment pointed to the
MTA family proteins rather than CHD3/CHD4 as the
direct H3 tail peptide-binding proteins within the NURD
complex (Figure 2B). Somewhat surprisingly, the H3
tail peptide binding activity was not mapped to the
N-terminal regions containing SANT and zinc finger
domains but to the C-terminal regions of MTA1 and
MTA2 that are not known for any recognizable structural
domain (Figure 3). We demonstrated that the purified re-
combinant C-terminal regions of MTA1 and MTA2 are
capable of binding H3 tail peptide (Figure 3C), and thus
designated the C-terminal region of MTA proteins as a
novel H3 binding domain (H3BD) (Figure 3C). Another
compelling evidence supporting the MTA proteins as the
H3 tail binding protein within the NURD complex came
from our analysis of 293T expressed N-terminal and
C-terminal fragments of MTA1 and MTA2 (Figure 4). The
N-terminal fragments of MTA1(1–460) was found to asso-
ciate with endogenous HDAC1/2 and RbAp48, whereas
the N-terminal MTA2(1–434) fragment was found to beincorporated into the HDAC1/2 complex containing also
CHD4. However, despite being incorporated into either par-
tial or complete endogenous NURD complex, both N-
terminal fragments bound poorly the H3 tail peptide in
in vitro pulldown assay (Figure 4B, C and E). In the con-
trary, although both the MTA1 C-terminal fragment 454–
715 and MTA2 C-terminal fragment 427–668 were not
found to associate with endogenous HDAC1/2 or CHD3/4
(Figure 4A and D), they exhibited a H3 tail peptide binding
activity as efficient as the corresponding full-length MTA
proteins (Figure 4B, C and E). Two conclusions can be
drawn from the above results. First, as the C-terminal
regions of MTA1 and MTA2 are not incorporated into the
endogenous NURD complex, they are clearly the autono-
mous H3 tail binding domain if considering together with
the H3 tail binding activity observed for their purified re-
combinant proteins (Figure 3C). Second, as the MTA2 N-
terminal fragment 1–434 expressed in 293T cells was
assembled into the NURD complex (as demonstrated by its
coimmunoprecipitation with endogenous CHD4 and
HDAC1 proteins) but failed to bind H3 tail peptide in vitro,
the MTA proteins but not CHD3/CHD4 is required for the
observed H3 tail peptide binding activity by NURD in vitro.
The MTA1 has been shown to play a role in transcrip-
tional regulation by an increasing number of transcription
factors including estrogen receptor and p53 [48,49]. It is
not clear at this stage whether in all these cases MTA1
functions within and/or outside the context of NURD
complex. The novel histone H3 binding activity uncovered
for MTA proteins in this study provides a physical link
between MTA proteins and chromatin. Future work is
necessary to illustrate the structural basis for specific
recognition of H3 tail by MTA family proteins.
Multiple mechanisms are likely to target the NURD
complex to chromatin
Although the MTA1(1–460) and MTA2(1–434) proteins
derived from 293T cells were not detected for H3 tail
peptide binding activity in vitro, we found both frag-
ments were associated with chromatin in 293T cells
(Figure 5). These results demonstrate that the NURD
complex can associate with chromatin independent of
the H3 binding activity of MTA proteins. One explan-
ation is that the NURD complex can be recruited to
chromatin by interaction with various transcription fac-
tors and/or other chromatin associated proteins such as
KAP1/TIF1, HP1 etc. In addition, the NURD complex
may associate with chromatin through the methylated
DNA binding activity of its MBD3 subunit. Furthermore,
although the subunits other than MTA proteins do not
appear to account for in vitro H3 binding specificity of
NURD, they may contribute to chromatin association
in vivo either through their broad histone interaction
and/or recognition of combinatorial chromatin elements.
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have been shown to bind histone H3 tail as well as H2A,
H2B and H4 tails [25]. In addition, both CHD3 and CHD4
subunits have been shown to bind H3 tail. The CHD3 and
CHD4 proteins form exclusive NURD complexes and each
contains a tandem PHD domain. The second PHD domain
of CHD4 was shown to bind H3 tail peptide and more re-
cently, the structural study revealed that the CHD4 tan-
dem PHD domain engages in a combinatorial fashion two
H3 tails in nucleosomes [23,24]. The combinatorial bind-
ing of two H3 tails by CHD4 may explain why CHD4 may
not account for the H3 tail peptide binding in vitro in our
experiments, yet contributes to chromatin association of
NURD complex in cells. Alternatively, the specific binding
of H3 tail peptide by NURD may be a combinatorial con-
sequence of H3 tail binding by more than one subunits of
the NURD complex, among them are the MTA family
proteins. The presence of multiple histone binding pro-
teins in the NURD complex may account for high affinity
interaction between NURD and H3 tail and broad function
of NURD in chromatin remodeling, transcription, DNA
damage repair and cell cycle.
Materials and methods
Plasmids, peptides, antibodies and cell lines
The plasmids pCDNA3-Flag-MTA1 and pcDNA3-Flag-
MTA3 were kind gift from Dr. Paul Wade (NIEHS). The
plasmids for pcDNA3-CHD3, pcDNA3-MTA2, pcDNA3-
p66 and pcDNA3-MDB3 were kindly provided by Dr. Yi
Zhang (Univ. of North Carolina). The plasmids for
HDAC1 and RbAp48and were described previously [50].
All MTA1 and MTA2 deletion mutants were generated
through PCR-based cloning in the pSG5-2×Flag vector.
The various H3 tail peptides used contain the H3N-
terminal amino acids 1–21 followed by a GGK lin-
ker sequence and a C-terminal biotin. The H2A, H2B
and H4 peptides are 1–21 aa of their corresponding
N-terminal tail sequences from human core histones
plus a C-terminal biotin. All peptides were synthesized
and purified by Scilight Biotechnology LLC (Beijing,
China). Antibodies against CHD3 and CHD4 were kindly
provided by Dr. Weidong Wang (NIA). The antibodies
against HDAC1/2 and NCoR were as described [40,51].
The anti-PHF8 monoclonal antibody was raised against
the 6×His-PHF8(aa1-418) and as described [31]. The com-
mercial antibodies are MTA1/2 (sc-9447, Santa Cruz),
Sin3A (Santa Cruz), Flag (Sigma) and H3 (abcam). HeLa
and 293T cell lines were obtained from the American
Type Culture Collection (ATCC, Manassas, VA).
In vitro pulldown of HeLa nuclear extracts or whole cell
extracts with immobilized histone tail peptides
The typical peptide based pulldowns were performed es-
sentially as described [52]. For pulldown of histone tailpeptide-binding proteins from HeLa nuclear extracts fol-
lowed by western blot analysis, approximately 1 μg of
histone tail peptides were first immobilized onto 10 μl
streptavidin-coated agarose beads and incubated with
approximately 250 μg of HeLa cell nuclear extracts or
whole cell extracts in 100 μl reaction with binding buffer
(20 mM HEPES [pH 7.9], 150 mM KCl, 1 mM dithio-
threitol [DTT], 1 mM phenylmethylsulfonyl fluoride
[PMSF], 10% glycerol, 0.1% NP-40, proteinase inhibitors)
for 3 h at 4°C. Unbound proteins were removed by
washing the beads with washing buffer (20 mM HEPES
[pH 7.9], 150 mM KCl, 1 mM DTT, 1 mM PMSF, 0.1%
NP-40, proteinase inhibitors) 4 times for 5 min each.
The proteins that remained bound to the peptides were
separated by SDS-PAGE followed by western blotting
analysis. For the experiment in Figure 1A, the pulldown
reaction was scaled up to 2 mg of HeLa nuclear extract
and the bound proteins were washed with the washing
buffer containing 250 mM KCl.
In-gel digestion and mass spectrometry
Sample preparation and mass spectrometry analysis on a
Finnigan LTQ mass spectrometer were as described pre-
viously [53].
In vitro pulldown of 35S-methionine-labeled proteins and
recombinant proteins with immobilized histone tail
peptides
For testing the H3 peptide-binding activity of individual
subunits of NURD complex, each subunit was synthe-
sized and 35S-methionine labeled using the TNT coupled
reticulocyte lysate system (Promega). The reactions were
diluted 1:10 with the binding buffer and subjected to
binding assays as above except that the binding of the
proteins was revealed by autoradiography. Similarly,
various MTA1 deletion mutants were synthesized and
35S-methionine labeled using the TNT system and ana-
lyzed for H3 tail peptide binding by in vitro pulldown.
For testing the direct binding of H3 peptide by MTA1
and MTA2, the recombinant 6xHis-MTA1(454–715)
and MTA2(427–668) were prepared from E.coli using
nickel beads according to manufacturer’s instruction.
The pulldown with recombinant proteins was performed
essentially as above except addition of 0.5 mg/ml BSA.
UV-induced cross-linking of H3Bpa peptide with MTA1
HeLa nuclear extracts (500 ug) or whole cell extracts
derived from Flag-MTA3 expressing 293T cells were
incubated with 1 ug immobilized H3 or H3Bpa peptide
as described above. After extensive washing, the beads
were exposed to 360 nm UV light source at a distance
of ~5 cm for various times as indicated. The beads were
then washed with NETN buffer (20 mM Tris pH 8.0,
200 mM NaCl, 1 mM EDTA and 1% NP40) with or
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100°C for 30 min to reverse cross-linking. The presence
of MTA family proteins and other subunits of NURD
complex were examined by western blot analysis.
Preparation of whole cell extracts and
immunoprecipitation
To examine the in vitro H3-binding activity of MTA1
and its deletion mutants expressed in mammalian cells,
plasmids (pSG5) encoding 2XFlag-tagged MTA1, MTA1
(1–460) and MTA1(454–715) were transfected into
293T cells via lipofection. Two days after transfection
the whole cell extracts were prepared and co-
immunoprecipitation and pulldown with H3 peptides
were performed essentially as described [52]. In addition,
Flag-MTA1 and its deletion mutants were further puri-
fied from whole cell extracts using anti-Flag M2 agarose
beads as described [54]. The resulting Flag-MTA1,
MTA1(1–460) and MTA1(454–715) protein complexes
were subjected to in vitro pulldown assay using immobi-
lized H3 peptides.
Chromatin isolation by cellular fractionation
To examine the chromatin association of MTA1 and its
deletion mutants, plasmids (pSG5) encoding 2XFlag or
GFP-tagged MTA1, MTA1(1–460) and MTA1(454–715)
were transfected into 293T cells via lipofection. Two
days posttransfection the cells were harvested and
washed with ice-cold PBS twice. The cells were resus-
pended in 200 μl of buffer A (10 mM HEPES, pH7.9,
10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% gly-
cerol, 1 mM DTT and protease inhibitor cocktail). To
lyze the cells, Triton X-100 was added to a final concen-
tration of 0.1%. The samples were incubated on ice for
8 min and centrifuged at 1500 rpm for 5 min. The
resulting cytoplasmic supernatants were designated as
fraction. The nuclei pellets (P1) were washed with buffer
A once and the resulting nuclei pellets were lysed in buf-
fer B (3 mM EDTA, 0.2 mM EGTA, 1 mM DTT and
protease inhibitor cocktail) and incubated on ice for
30 min. The samples were centrifuged at 3500 rpm for
5 min and the resulting chromatin pellets were desig-
nated. To test the stability of MTA1 chromatin associ-
ation, the pellets were resuspended with 5 volume of
buffer B containing 150 mM, 250 mM and 350 mM
NaCl respectively and incubated in ice for 30 min. The
samples were centrifuged at 10000 rpm for 10 min and
the resulting supernatants and pellets were designated.
The Western blot analyses were performed using anti-
bodies as indicated.
To examine the chromatin association by sucrose gra-
dient centrifugation, the 293T cells expressing GFP-
tagged MTA1 proteins in 10 cm culture dishes were
treated with 1% formaldehyde for 10 min at roomtemperature with slow rotation. The cross-linking reac-
tions were quenched by addition of glycine to 0.1 M.
The cells were rinsed with PBS twice and lysed with
500 μl lysis buffer (10 mM Tris–HCl pH 7.5, 10 mM
NaCl, 0.5% NP-40, 1 mM DTT and protease inhibitor
cocktail). After centrifugation at 3500 rpm for 5 min to
remove the supernatants, the nuclei pellets were washed
with ice-cold PBS once and resuspended in 600 μl of
MNase digestion buffer (50 mM Tris–HCl, pH 7.6,
1 mM CaCl2, 0.2% Triton X-100 and protease inhibitor
cocktail). MNase was added to a final concentration of
0.5 U/μl and incubated at 37°C for 20 min. The digestion
was stopped by addition of EDTA to a final 10 mM. The
samples were centrifuged at 15000 rpm for 15 min and
the resulting soluble chromatin preparations were sub-
jected to 5-30% sucrose gradient centrifugation.
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